EAVI2020 EAVI2020 on Twitter EAVI2020 on Facebook EAVI2020 on LinkedIn

University of New South Wales (UNSW Australia)

The Kirby Institute, UNSW Australia, is a leading global research institute dedicated to the prevention and treatment of HIV, viral hepatitis and sexually transmissible infections. The Institute has a staff of over 260 public health, clinical and laboratory scientists, research assistants and postgraduate students.

The EAVI2020 grant will give the Australian researchers an opportunity to engage in forum for the free exchange of cutting edge ideas for vaccine design, provide a pipeline for the rapid pre-clinical and clearly phase clinical testing of their most promising constructs, and allow access to expertise for in depth study of the immune responses these vaccines induce.

http://kirby.unsw.edu.au/

Professor Anthony Kelleher

Tony Kelleher is professor of Medicine at University of NSW, where he is head of the Immunovirology and Pathogenesis program at the Kirby Institute. He holds appointments at St Vincent’s Hospital Sydney, as a clinical Immunologist and Immunopathologist where he helps run the diagnostic services for HIV/AIDS and immunological conditions. His research interests encompass the immunovirology of HIV infection, particularly understanding the co-evolution of the virus and the T cell immune responses that control it. He has lead several trials of putative vaccines and antiretroviral therapies and coordinates a number of cohort studies in pathogenically informative populations such as long term non-progressors. He is developing a novel strategy for silencing viral transcription, based on novel siRNA technology, which is being developed towards testing in the clinic as a route towards a functional cure of HIV infection.

akelleher@kirby.unsw.edu.au

Courtney Bendall

Courtney Bendall supports and manages the operational and administrative aspects of research grants for Professor David Cooper, Professor Miles Davenport and Professor Anthony Kelleher.

cbendall@kirby.unsw.edu.au